Baillie Gifford - EXELIXIS INC ownership

EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 397 filers reported holding EXELIXIS INC in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.3%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of EXELIXIS INC
ValueSharesWeighting
Q1 2023$27,077
+37.2%
1,395
+13.4%
0.00%
Q4 2022$19,729
+3.8%
1,2300.0%0.00%
Q3 2022$19,000
-26.9%
1,2300.0%0.00%
Q2 2022$26,000
-3.7%
1,230
+2.5%
0.00%
Q1 2022$27,000
+22.7%
1,2000.0%0.00%
Q4 2021$22,000
-12.0%
1,2000.0%0.00%
Q3 2021$25,000
-73.1%
1,200
-92.5%
0.00%
Q3 2013$93,000
+29.2%
15,9120.0%0.00%
Q2 2013$72,00015,9120.00%
Other shareholders
EXELIXIS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Meditor Group Ltd 15,001,073$265,294,00064.62%
Sargent Investment Group, LLC 465,620$8,234,0003.70%
Orbimed Advisors 3,912,900$69,200,0001.31%
Bellevue Group AG 3,858,700$68,241,0001.27%
TEALWOOD ASSET MANAGEMENT INC 137,129$2,425,0001.04%
CAPITAL MANAGEMENT CORP /VA 200,995$3,555,0000.97%
Penn Capital Management Company, LLC 517,988$9,161,0000.96%
Chicago Capital, LLC 801,560$14,176,0000.95%
Portolan Capital Management 454,444$8,037,0000.91%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 103,534$1,830,0000.85%
View complete list of EXELIXIS INC shareholders